BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25981639)

  • 1. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
    Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
    BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-seq identifies determinants of oxaliplatin sensitivity in colorectal cancer cell lines.
    Li XX; Peng JJ; Liang L; Huang LY; Li DW; Shi DB; Zheng HT; Cai SJ
    Int J Clin Exp Pathol; 2014; 7(7):3763-70. PubMed ID: 25120752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells.
    Li Y; Luo W; Zhang H; Wang C; Yu C; Jiang Z; Zhang W
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443490
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jung EJ; Kim HJ; Shin SC; Kim GS; Jung JM; Hong SC; Kim CW; Lee WS
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MT2A Promotes Oxaliplatin Resistance in Colorectal Cancer Cells.
    Zhao Z; Zhang G; Li W
    Cell Biochem Biophys; 2020 Dec; 78(4):475-482. PubMed ID: 32638210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection Role of Vitamin C by Upregulating Glutamate Transporter-1 in Auditory Cortex of Noise-Induced Tinnitus Animal Model.
    Cao W; Xiong S; Ji W; Wei H; Ma F; Mao L
    ACS Chem Neurosci; 2024 Mar; 15(6):1197-1205. PubMed ID: 38451201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forebrain EAAT3 Overexpression Increases Susceptibility to Amphetamine-Induced Repetitive Behaviors.
    Kopelman JM; Chohan MO; Hsu AI; Yttri EA; Veenstra-VanderWeele J; Ahmari SE
    eNeuro; 2024 Apr; 11(4):. PubMed ID: 38514191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into disease-associated glutamate transporter (EAAT1 /
    Gorostiola González M; Sijben HJ; Dall' Acqua L; Liu R; IJzerman AP; Heitman LH; van Westen GJP
    Front Mol Biosci; 2023; 10():1286673. PubMed ID: 38074092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate-mediated Resistance to Trichostatin A Accompanied by Elevated Expression of Glucose Transporter 3 (GLUT3) in Human Colorectal Carcinoma HCT116 Cells.
    Khonthun C; Surangkul D
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4085-4092. PubMed ID: 38156841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licochalcone C Inhibits the Growth of Human Colorectal Cancer HCT116 Cells Resistant to Oxaliplatin.
    Lee SO; Joo SH; Lee JY; Kwak AW; Kim KT; Cho SS; Yoon G; Choi YH; Park JW; Shim JH
    Biomol Ther (Seoul); 2024 Jan; 32(1):104-114. PubMed ID: 38148556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of chromatin high-order conformation associated with oxaliplatin resistance acquisition in colorectal cancer cells.
    Li P; Shang X; Jiao Q; Mi Q; Zhu M; Ren Y; Li J; Li L; Liu J; Wang C; Shi Y; Wang Y; Du L
    Exploration (Beijing); 2023 Aug; 3(4):20220136. PubMed ID: 37933235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rational modulation of autophagy sensitizes colorectal cancer cells to 5-fluouracil and oxaliplatin.
    Baldasso-Zanon A; Silva AO; Franco N; Picon RV; Lenz G; Lopez PLDC; Filippi-Chiela EC
    J Cell Biochem; 2024 Feb; 125(2):e30517. PubMed ID: 38224178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Short-Term Glucose Starvation and Chemotherapy in 3D Colorectal Cancer Cell Culture Decreases 14-3-3 Family Protein Expression and Phenotypic Response to Therapy.
    Schroll MM; Ludwig KR; LaBonia GJ; Herring EL; Hummon AB
    J Am Soc Mass Spectrom; 2018 Oct; 29(10):2012-2022. PubMed ID: 30019162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glutamate/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survival.
    Stanulović VS; Al Omair S; Reed MAC; Roberts J; Potluri S; Fulton-Ward T; Gudgeon N; Bishop EL; Roels J; Perry TA; Sarkar S; Pratt G; Taghon T; Dimeloe S; Günther UL; Ludwig C; Hoogenkamp M
    Haematologica; 2024 May; ():. PubMed ID: 38813748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.
    Shimamoto K; Lebrun B; Yasuda-Kamatani Y; Sakaitani M; Shigeri Y; Yumoto N; Nakajima T
    Mol Pharmacol; 1998 Feb; 53(2):195-201. PubMed ID: 9463476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer.
    Lin X; Stenvang J; Rasmussen MH; Zhu S; Jensen NF; Tarpgaard LS; Yang G; Belling K; Andersen CL; Li J; Bolund L; Brünner N
    BMC Genomics; 2015 May; 16(1):404. PubMed ID: 25997618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of an alternating regimen consisting of first-line mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: FIREFOX plus bevacizumab trial (KSCC0801).
    Miwa K; Oki E; Emi Y; Saeki H; Kusumoto T; Akagi Y; Ogata Y; Samura H; Tokunaga S; Ishikawa H; Tanaka T; Sueyoshi S; Higashi H; Matsuda H; Touyama T; Maehara Y;
    Int J Clin Oncol; 2016 Feb; 21(1):110-7. PubMed ID: 26037783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.
    Klaver CE; Musters GD; Bemelman WA; Punt CJ; Verwaal VJ; Dijkgraaf MG; Aalbers AG; van der Bilt JD; Boerma D; Bremers AJ; Burger JW; Buskens CJ; Evers P; van Ginkel RJ; van Grevenstein WM; Hemmer PH; de Hingh IH; Lammers LA; van Leeuwen BL; Meijerink WJ; Nienhuijs SW; Pon J; Radema SA; van Ramshorst B; Snaebjornsson P; Tuynman JB; Te Velde EA; Wiezer MJ; de Wilt JH; Tanis PJ
    BMC Cancer; 2015 May; 15():428. PubMed ID: 26003804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases.
    Hofman J; Skarka A; Havrankova J; Wsol V
    Biochem Pharmacol; 2015 Aug; 96(3):168-78. PubMed ID: 25986883
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.